In this issue:

Member & Local News

  • Cangene Names John A. Sedor as President and Chief Executive Officer
  • Solanyl Working to Develop Brand, Pursue new Ideas and Transition From a Commodity Based Business to a Value-added Business.  
  • Valeant Pharma Completes Purchase of AB Sanitas 
  • Government of Canada Investment Fires up Business for Flax Producers 

Learn how a Manitoba Company is Using Manitoba Flax and Hemp to Prevent Soil Erosion

Life Science in the News  

  • FDA Unveils New Regulatory Science Strategy  
  • Shrinking of “Bioproducts” Sector a Worrisome Trend  
  • Biotech and Pharma see M&A Increase in 2011’s First Half   
  • Sales of Natural Fibres for use in Composites set to Double by 2015


and more

Access the newsletter here

About the Life Science Association of Manitoba (LSAM): 

LSAM represents all those involved in the Life Science Sector in Manitoba. The Life Science Sector focuses on the use of innovative biological tools and products, the creation of wealth and sustainability in the production of medical treatments, diagnostics, more-nutritional foods, energy, chemicals, and materials, while improving the quality of the environment.

The Life Science sector is a key to economic growth within the Province of Manitoba and is currently estimated to contribute more than 7% of the province’s GDP. In addition to generating value on its own, the Life Science sector is helping to grow and sustain competitiveness in ailing and traditional sectors of the economy, through the application of new and innovative products and processes. 

To find out more about LSAM visit its website here